Nurix Therapeutics (NRIX) Other Gross PP&E Adjustments: 2019-2025
Historic Other Gross PP&E Adjustments for Nurix Therapeutics (NRIX) over the last 5 years, with Aug 2025 value amounting to $5.7 million.
- Nurix Therapeutics' Other Gross PP&E Adjustments fell 71.64% to $5.7 million in Q3 2025 from the same period last year, while for Aug 2025 it was $105.0 million, marking a year-over-year increase of 77.29%. This contributed to the annual value of $22.5 million for FY2024, which is 249.29% up from last year.
- Latest data reveals that Nurix Therapeutics reported Other Gross PP&E Adjustments of $5.7 million as of Q3 2025, which was down 88.43% from $49.7 million recorded in Q2 2025.
- In the past 5 years, Nurix Therapeutics' Other Gross PP&E Adjustments ranged from a high of $49.7 million in Q2 2025 and a low of $5.7 million during Q3 2025.
- In the last 3 years, Nurix Therapeutics' Other Gross PP&E Adjustments had a median value of $22.5 million in 2024 and averaged $22.8 million.
- Per our database at Business Quant, Nurix Therapeutics' Other Gross PP&E Adjustments surged by 249.29% in 2024 and then crashed by 71.64% in 2025.
- Quarterly analysis of 5 years shows Nurix Therapeutics' Other Gross PP&E Adjustments stood at $11.2 million in 2021, then skyrocketed by 84.96% to $20.6 million in 2022, then plummeted by 68.79% to $6.4 million in 2023, then surged by 249.29% to $22.5 million in 2024, then tumbled by 71.64% to $5.7 million in 2025.
- Its last three reported values are $5.7 million in Q3 2025, $49.7 million for Q2 2025, and $27.1 million during Q1 2025.